Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RiaSTAP in Aortic Reconstruction
NCT01300286Phase 4Completed
- Sponsor
- Duke University
- Start
- Dec 2010
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Fibrinogen human in coagulopathy, sponsored by Duke University. Started Dec 2010; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
coagulopathy
Beyond the preview
Go deeper on NCT01300286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01300286.